Urine Hormone Test

Comprehensive Sex Hormone Profile and Detox of Metabolic Pathways

Our most frequently requested dried urine hormone panel, designed to provide an integrated evaluation of sex hormone production and detoxification pathways. By capturing hormone levels across a full 24-hour period, it delivers a dynamic representation of synthesis, metabolism, and clearance that cannot be obtained from single-point serum or saliva testing.

---

Clinical Utility

This panel is particularly valuable for:

• Characterizing estrogen metabolism and identifying unfavorable pathways that may increase cancer risk or impair detoxification.

• Monitoring sex hormone balance in patients on or considering hormone replacement therapy (HRT) or bioidentical hormone therapy (BHRT).

• Providing data to guide support in cases of chronic fatigue, mood disturbance, metabolic resistance, sleep disruption, or perimenopausal/menopausal symptoms.

---

Biomarkers Included

The Hormone Profile evaluates a broad spectrum of hormones and metabolites:

• Estrogens: estrone (E1), estradiol (E2), and estriol (E3)

• Estrogen metabolites: phase I and phase II breakdown products, relevant for cancer risk assessment and detoxification efficiency

• Progesterone metabolite: pregnanediol, reflecting luteal sufficiency and progesterone bioavailability

• Androgens: testosterone, DHEA, and their downstream metabolites, providing insight into anabolic status and androgen excess or deficiency

---

Methodology

Specimens are collected using a dried urine technique, offering a non-invasive, convenient, and client-compliant method suitable for at-home collection. The assay provides reliable quantification of free and conjugated hormones, enhancing interpretive accuracy. This cost includes a 30-minute consultation with a seasoned integrative practitioner.

---

 

Clinical Applications

The Balance Profile is indicated for patients presenting with:

• Chronic fatigue, low resilience, or mood instability

• Vasomotor instability (hot flashes, night sweats)

• Menstrual irregularities or perimenopausal transitions

• Unexplained weight gain or low libido

• Need for monitoring or adjusting hormone therapy

• Support for cancer

---

This panel supports evidence-based, individualized planning, allowing providers to address both hormone production and clearance for optimal clinical outcomes.